Q2 2026 saw 26% revenue growth, margin expansion, and a return to profitability, with strong clinician and visit growth. FY 2026 guidance was raised across revenue, margin, and EBITDA, reflecting continued operational momentum and disciplined capital deployment.Original document: LifeStance Health…
Behavioral health company LifeStance Health NASDAQ:LFSTwill be announcing earnings results this Thursday morning. Here’s what investors should know.LifeStance Health Group beat analysts’ revenue expectations last quarter, reporting revenues of $403.5 million, up 21.2% year on year. It was an except…
LifeStance Health appointed Thurman Justice, Lori Goltermann and Safwan Shabab to its board after Jeffrey Rhodes resigned from the board and all committees, effective July 2, 2026.Original SEC Filing: LifeStance Health Group, Inc. [ LFST ] - 8-K - Jul. 07, 2026This is an AI-powered summary. It may…
Wall Street wrapped up a holiday-shortened last week with a mixed but encouraging picture. The Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite index closed the week with gains of 1.4%, 0.6% and 0.05%, respectively. Investor confidence was supported by easing tensions in the Midd…
